As the medical device industry rapidly expands, so does the need for executive leadership. Recently, several top executives have made moves within the industry. Some have taken new positions at other companies, while others have started their own businesses. Here’s a look at who’s been making headlines lately.
Appoints Professor Nada Jabado and Professor Burkhard Becher to its scientific advisory board.
With more than two decades of finance and accounting expertise, Dalen brings extensive experience in scaling private and public companies to his new role.
Dan Cummings will be responsible for Precision AQ’s commercial and go-to-market strategies, with the goal of bringing Precision AQ’s comprehensive suite of capabilities to help biopharmaceutical companies advance life-changing therapies to market.
Brennan will transition out of the chief financial officer position at the end of June and is expected to remain with Boston Scientific as a senior advisor through early October 2025.
“We recognize the MedTech industry is consistently changing and remain committed to providing flexible solution-driven partnerships that guide our clients from concept to commercialization. Our ability to navigate the changes in the industry is rooted in the strength of our team,” said Jason Monteleone, president and CEO of Avania.
Dr Del Trezise succeeds Melanie Leveridge, who successfully completed her four-year term as Chair.